Physician profile
Bennett Cua
NPI 1962791772
$12,535.68
in general payments reported to CMS, 2019-2025
45 companies · $1,731 in 2025
The $1,731 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,243 · 2020: $380 · 2021: $540 · 2022: $1,943 · 2023: $1,962 · 2024: $1,737 · 2025: $1,731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,429.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,811.82 | 2019-2025 | Xience Skypoint, Ensite, Pressurewire |
| Amgen INC. | $1,264.46 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $1,222.21 | 2019-2025 | |
| Boston Scientific Corporation | $939.96 | 2019-2025 | Rotapro, Avvigo Guidance System, General - Crm_crm |
| Pfizer INC. | $823.72 | 2019-2025 | |
| Alnylam Pharmaceuticals INC. | $605.95 | 2022-2025 | Amvuttra, Onpattro |
| E.R. Squibb & Sons, L.L.C. | $570.72 | 2022-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $480.26 | 2022-2025 | Verquvo, Capvaxive |
| Janssen Pharmaceuticals, INC | $480.06 | 2019-2024 | Xarelto |
| Cardiovascular Systems INC. | $330.48 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $326.85 | 2019-2024 | Farxiga, Wainua |
| Boehringer Ingelheim Pharmaceuticals, INC. | $322.99 | 2019-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $318.67 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $281.99 | 2019-2025 | Lifevest |
| Kiniksa Pharmaceuticals, LTD. | $242.58 | 2022-2023 | Arcalyst |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $240.36 | 2021-2024 | Kengreal |
| Abiomed | $209.83 | 2020-2025 | |
| Biotronik INC. | $198.42 | 2019-2020 | |
| Corindus INC. | $163.36 | 2019 | |
| Medtronic Vascular, INC. | $161.44 | 2019-2020 | |
| Edwards Lifesciences Corporation | $159.96 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Shockwave Medical, INC | $146.93 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Irhythm Technologies, INC. | $130.00 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Kestra Medical Technology Services, INC. | $129.19 | 2023-2025 | Assure Wcd |
| Regeneron Healthcare Solutions, INC. | $126.74 | 2019-2025 | Evkeeza |
| Cardinal Health 200 LLC | $117.13 | 2019 | |
| Sanofi-Aventis U.S. LLC | $110.40 | 2019-2024 | |
| Novo Nordisk INC | $90.02 | 2022-2025 | Ozempic |
| Esperion Therapeutics, INC. | $55.72 | 2022-2023 | Nexletol |
| Acist Medical Systems, INC. | $47.88 | 2024-2025 | |
| Amarin Pharma, INC. | $43.79 | 2020 | |
| Impulse Dynamics (USA) INC. | $40.85 | 2022 | |
| Philips North America LLC | $40.15 | 2019 | |
| Portola Pharmaceuticals, LLC | $38.62 | 2019 | |
| Inari Medical, INC. | $35.72 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Angiodynamics, INC. | $29.98 | 2023 | Alphavac |
| Kiniksa Pharmaceuticals International, Plc | $26.68 | 2024 | Arcalyst |
| Heartflow, INC. | $26.28 | 2023 | Ffrct |
| Kowa Pharmaceuticals America, INC. | $24.50 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $23.62 | 2019 | |
| Astellas Pharma US INC | $21.95 | 2020 | |
| Cathworks, INC. | $21.29 | 2019 | |
| Medtronic, INC. | $19.39 | 2024 | Onyx Frontier |
| Lundbeck LLC | $16.62 | 2019 | |
| Bridgebio Pharma, INC. | $16.14 | 2025 | Attruby |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bennett Cua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.